References
- Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood J Am Soc Hematol. 2010;115(22):43316.
- Sheiner E, Levy A, Yerushalmi R, Katz M. Beta-thalassemia minor during pregnancy. Obstet Gynecol. 2004;103(6):12737.
- Shanik MH, Xu Y, Skrha J, Dankner R, Zick Y, Roth J. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care. 2008;31(Supplement_2):S262-8.
- Cappellini MD, Porter JB, Viprakasit V, Taher AT. A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies? Blood Rev. 2018;32(4):300-11.
- Attar S, Bakhshani Nm, Aliabad Qm. An investigation on the frequency of thoughts, readiness and suicide attempt in individuals with thalassemia. Pakistan J Med Heal Sci. 2021;15(6):1847-53.
- Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood, J Am Soc Hematol. 2010;115(10):1886-92.
- Musallam KM, Taher AT, Karimi M, Rachmilewitz EA. Cerebral infarction in β-thalassemia intermedia: breaking the silence. Thromb Res. 2012;130(5):695-702.
- Cappellini M, Cohen A, Eleftheriou A, Piga A, Porter J, Taher A. Guidelines for the clinical management of thalassaemia. Nicosia (CY): Thalassaemia International Federation; 2014.
- Taher A, Vichinsky E, Musallam K, Cappellini M-D, Viprakasit V. Guidelines for the management of non transfusion dependent thalassaemia (NTDT). Nicosia: Thalassaemia International Federation; 2013.
- Bujak M, Bujak IT, Sobočanec S, Mihalj M, Novak S, Cosić A, et al. Trefoil Factor 3 deficiency affects liver lipid metabolism. Cell Physiol Biochem. 2018;47(2):827-41.
- Huang YG, Li YF, Wang LP, Zhang Y. Aberrant expression of trefoil factor 3 is associated with colorectal carcinoma metastasis. J Cancer Res Ther. 2013;9(3):376-80.
- Li Q, Wang K, Su C, Fang J. Serum Trefoil Factor 3 as a protein biomarker for the diagnosis of colorectal cancer. Technol Cancer Res Treat. 2017;16(4):440-5.
- Große-Kreul J, Busch M, Winter C, Pikos S, Stephan H, Dünker N. Forced Trefoil Factor Family Peptide 3 (TFF3) expression reduces growth, viability, and tumorigenicity of human retinoblastoma cell lines. PLoS One. 2016;11(9):1-21.
- Suemori S, Lynch-Devaney K, Podolsky DK. Identification and characterization of rat intestinal trefoil factor: tissue-and cell-specific member of the trefoil protein family. Proc Natl Acad Sci. 1991;88(24):11017-21.
- Xu L, Teng X, Guo J, Sun M. Protective effect of intestinal trefoil factor on injury of intestinal epithelial tight junction induced by platelet activating factor. Inflammation. 2012;35:308-15.
- Sun Y, Wang L, Zhou Y, Mao X, Deng X. Cloning and characterization of the human trefoil factor 3 gene promoter. PLoS One. 2014;9(4):e95562.
- Bulitta CJ, Fleming JV, Raychowdhury R, Taupin D, Rosenberg I, Wang TC. Autoinduction of the trefoil factor 2 (TFF2) promoter requires an upstream cis-acting element. Biochem Biophys Res Commun. 2002;293(1):366-74.
- Aravind K, Poornima T, Sibasis SS, Kumar SA. Prevalence of insulin resistance: a prospective study in North Indian population. Indian J Clin Biochem. 2005;20:10-7.
- McDougall KE, Stewart AJ, Argiriou AM, Huggins CE, New PW. Comparison of three methods for measuring height in rehabilitation inpatients and the impact on body mass index classification: An open prospective study. Nutr Diet. 2018;75(1):123-8.
- Marengo-Rowe AJ. The thalassemias and related disorders. In: Baylor university medical center proceedings. Taylor & Francis; 2007:27-31.
- Galanello R. Recent advances in the molecular understanding of non-transfusion-dependent thalassemia. Blood Rev. 2012;26:S7-11.
- Koeppen AH. The history of iron in the brain. J Neurol Sci. 1995;134:1-9.
- Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 2014;13(10):1045-60.
- Andrews NC. Iron homeostasis: insights from genetics and animal models. Nat Rev Genet. 2000;1(3):208-17.
- De Jong G, Van Dijk JP, Van Eijk HG. The biology of transferrin. Clin Chim Acta. 1990;190(1-2):1-46.
- Zecca L, Youdim MBH, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci. 2004;5(11):863-73.
- Kosaryan M, Aliasgharian A, Mousavi M, Roshan P. Diagnostic value of fructosamine and glycosylated hemoglobin in estimating blood glucose level in diabetic patients with thalassemia major. Med Lab J. 2013;7(3):16-23.
- Politou M, Kalotychou V, Pissia M, Rombos Y, Sakellaropoulos N, Papanikolaou G. The impact of the mutations of the HFE gene and of the SLC11A3 gene on iron overload in Greek thalassemia intermedia and beta (s)/beta (thal) anemia patients. Haematologica. 2004;89(4):490-2.
- Steinberg MH, Forget BG, Higgs DR, Weatherall DJ. Disorders of hemoglobin: genetics, pathophysiology, and clinical management. Cambridge University Press; 2009.
- Elmrghni S, Dixon RA, Williams DR. Frequencies of HFE gene mutations associated with haemochromatosis in the population of Libya living in Benghazi. Int J Clin Exp Med. 2011;4(3):200.
- Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev. 1995;75(3):473-86.
- Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005;26(2):19.
- Lann D, LeRoith D. Insulin resistance as the underlying cause for the metabolic syndrome. Med Clin North Am. 2007;91(6):1063-77.
- Gallagher EJ, LeRoith D, Karnieli E. Insulin resistance in obesity as the underlying cause for the metabolic syndrome. Mt Sinai J Med A J Transl Pers Med. 2010;77(5):511-23.
- Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17:1-14.
- Ge H, Gardner J, Wu X, Rulifson I, Wang J, Xiong Y, et al. Trefoil factor 3 (TFF3) is regulated by food intake, improves glucose tolerance and induces mucinous metaplasia. PLoS One. 2015;10(6):e0126924.
- Fueger PT, Schisler JC, Lu D, Babu DA, Mirmira RG, Newgard CB, et al. Trefoil factor 3 stimulates human and rodent pancreatic islet β-cell replication with retention of function. Mol Endocrinol. 2008;22(5):1251-9.
- Paulsen FP, Berry MS. Mucins and TFF peptides of the tear film and lacrimal apparatus. Prog Histochem Cytochem. 2006;41(1):1-53.
- Krüger K, Schmid S, Paulsen F, Ignatius A, Klinger P, Hotfiel T, et al. Trefoil factor 3 (TFF3) is involved in cell migration for skeletal repair. Int J Mol Sci. 2019;20(17):1-13.
- Otto WR, Thim L. Trefoil factors: Trefoil factor family-interacting proteins. Cell Mol Life Sci C. 2005;62:2939-46.